Economic burden of hepatitis B infection among patients with diabetes

Despite ACIP recommendation and cost-effectiveness established in those 19–59 y old diabetes patients the uptake of Hepatitis B vaccine in diabetes patients is low. There is need to highlight the impact of Hepatitis B virus (HBV) infection in diabetes patients in terms of healthcare utilization and...

Descripción completa

Detalles Bibliográficos
Autores principales: Deshpande, Gaurav, Klink, Andrew J., Shenolikar, Rahul, Singer, Joseph, Eisenberg Lawrence, Debra F., Krishnarajah, Girishanthy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963070/
https://www.ncbi.nlm.nih.gov/pubmed/27050021
http://dx.doi.org/10.1080/21645515.2015.1127488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963070/
https://www.ncbi.nlm.nih.gov/pubmed/27050021
http://dx.doi.org/10.1080/21645515.2015.1127488

Ejemplares similares